- Desalting and buffer exchange are crucial downstream bioprocessing steps that involve the removal of salts and small molecules or the replacement of buffer solutions, essential for preparing biological samples, particularly proteins and nucleic acids, for various analytical and purification applications
- The escalating demand for desalting and buffer exchange solutions is primarily fueled by the burgeoning biopharmaceutical sector, increasing research and development expenditure in proteomics and genomics, and the growing focus on the production of biologics, including monoclonal antibodies and vaccines
- North America dominates the desalting and buffer exchange market with the largest revenue share of 22.3% in 2024, characterized by high R&D investment in biopharmaceuticals, a strong presence of key industry players, and increasing demand for advanced purification processes in the U.S. and Canada
- Asia-Pacific is expected to be the fastest growing region in the desalting and buffer exchange market with a CAGR of 11.1%, during the forecast period due to the rapid expansion of the biotechnology industry, increasing investments in life sciences research, and the rising demand for biopharmaceuticals in countries
- Filtration segment dominates the desalting and buffer exchange market with a market share of 44.2% in 2024, driven by its efficiency in removing salts and exchanging buffers in large-scale bioprocessing operations, its speed compared to other methods such as dialysis, and its ability to concentrate samples simultaneously
